Question to the Department of Health and Social Care:

To ask His Majesty's Government what support they are providing to NHS Trusts to restore or replace paused CAR-T clinical trials, to prevent patients being left without viable treatment pathways.

The Department is committed to turbocharging clinical research and ensuring that all patients, including those with cancer, have access to cutting-edge clinical trials and innovative, lifesaving treatments.

Decisions about whether a specific clinical trial should be paused are the responsibility of the study sponsor and research team, who closely monitor any reported patient safety concerns and other data that could impact a decision for an individual trial to be halted.

To support National Health Service trusts to deliver clinical trials, the Department funds research and research infrastructure across England through the National Institute for Health and Care Research, which supports patients and the public to participate in high-quality research, including on CAR-T therapy.